Description
Survodutide research peptide
Survodutide is an investigational peptide that activates both the GLP-1 receptor and the glucagon receptor. The dual mechanism is studied for its combined effects on satiety signalling and energy expenditure.
Product details
| Compound | Survodutide |
|---|---|
| Class | Dual GLP-1 / glucagon receptor agonist |
| Format | Lyophilised peptide vial |
| Labelling | Compound name and strength on every container |
What research has examined
- Dual agonism: balancing GLP-1 and glucagon receptor activity.
- Liver metabolism: hepatic fat endpoints in clinical research.
- Clinical programme: phase 2 and phase 3 trials in metabolic disease.
Research interest does not establish a proven effect in humans.
Regulatory status
This compound is not an approved medicine. It is supplied only as a research chemical for laboratory use.
Storage and handling
Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.
Related research products
Adamax / Adalank Combo Pack · Healing Research Bundle · Turn Back Time Bundle · All peptides
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.